HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.

Slides:

Advertisements

Similar presentations

Cancer Research UK strategy and funding Simon Vincent.

Advertisements

Inside St Vincent’s Health insights from inside one of Australia’s leading hospitals Professor Allan Spigelman - Director of Cancer Services at St Vincents.

Supporting people who use drugs & providers: hep C info & care Magdalena Harris London School of Hygiene and Tropical Medicine

0 This document is CONFIDENTIAL and its distribution and use are RESTRICTED © 2012 KPMG LLP, a UK limited liability partnership and a member firm of the.

DRAFT, IN PREPARATION Regional Voices for Better Health Dr Paul Plant Deputy Director Health Improvement Public Health England (London Region)

Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London.

Claire Munro Co-facilitator London Joint Working Group on Substance Use and Hepatitis C The role of technology in supporting patient pathways.

Reducing blockages in the pathway to Hepatitis C treatment Emma Burke, PHE.

The LJWG 2014 conference is funded through educational grants from AbbVie Ltd, Gilead Sciences Ltd and MSD Ltd and sponsored by Bristol-Myers Squibb. None.

HIV Research – A Unique UWF Connection. Dr. Michael Summer B.S. Chemistry – UWF PhD Chemistry – Emory University Professor, University of Maryland, Baltimore.

1 A consistent approach to personalised care Designing for care Dr Paul Whatling Senior Clinical Consultant.

WELCOME EXPERIENCE PHARMACY AT KING’S. Timetable 12:00Introduction 12:15Mini-lectures: Medicines Optimisation |The Science Perspective |The Clinical Perspective.

CPD accreditation (3 points) applied for Invitation Organised by Dr Handrean Soran & Dr Naveed Younis The organisers will not receive speaker honorarium.

North West London LETB Board – 1 st meeting 12 Nov November Purpose: To plan and commission education & training to ensure a highly skilled and appropriate.

Standards Debate at the Centre for Better Managed Health Care, Cass Business School, City University London, 26 th October Professor Mike Kelly Director.

بسم الله الرحمن الرحیم International Health Dr Arash Rashidian Assistant Professor, Department of Health Economics and Management Sciences, School of Public.

Evaluating a whole systems approach to integrated care in North West London Nuffield Trust & London School of Economics 22 June 2015 Holly Holder

Clinical Academic Training Pathway Dr Professor Waljit S Dhillo.

22 nd September 2011 Imperial College, London Welcome The Industrial Emissions Directive.

The Liverpool Care Pathway What have we learned which should guide the future? 1. Clinical issues 2. Health system issues 3. Societal issues 4. Scottish.

Improving services for people with low vision: an evaluation of the work of the Low Vision Services Committees Andrew Gibson, Research Fellow, Institute.

Improving services for people with low vision: an evaluation of the work of the Low Vision Services Committees Andrew Gibson, Research Fellow, Institute.

CHFG OPEN SEMINAR ROLE OF: CLINICAL DIRECTOR: CLINICAL HUMAN FACTORS, SIMULATION TRAINING AND ETHICS HYWEL DDA HEALTH BOARD Dr Matthew Sargeant.

Unit 11 Power Notes – Part 1 Science, Technology and Medicine in the mid to late 20 th century (Chapter 24-26)

Dr Ashley Brown Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, London and Honorary Senior Lecturer, Imperial College London The Updated.

Directory of Services in detail Defining services Service builder overview Workgroups Commissioning Implementation considerations Slot management Service.

The need for an Academy The Academy will play its unique part in helping to shape new landscapes emerging from research policies.

The Role of Health Care Needs Assessment Dr. Siân Griffiths Specialist Registrar in Public Health.

The DART Trial Evaluates two strategies for delivering ART, comparing: clinical monitoring only with routine laboratory + clinical monitoring structured.

Medical Technology Essential Questions:

#LJWG2015 HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.

#LJWG2015 HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.

#LJWG2015 HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.

Beyond the Walls of the Clinic: The Importance of Collaboration with Community Organizations to Address Viral Hepatitis Dawn Fishbein, MD, MS Scientific.

#LJWG2015 HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.

Bringing Science to Addiction Services TRAINING INSTITUTE.

Homelessness & mental health Dr Philip Timms Consultant Psychiatrist, START Team Honorary Senior Lecturer, King's College London.

CREATING, NURTURING AND PROTECTING COMMUNITY SPACE M ARIO SOBCZAK COORDINATOR RECOVERY INITIATIVE SOCIAL ENTERPRISE COMMUNITY INTEREST COMPANY “Working.

#LJWG2015 HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.

EDGE™ Final Project Plan Presentation P09001 – RFID Reader & Active Tag Philip Davenport (Industrial and Systems Engineering)

Reducing the burden - improving services The Health and Social Care Information Centre Martin Machray Release: 1 April 2005.

Dr Thomas V Taylor Former Professor of Anatomy Dr. Thomas V. Taylor taught anatomy at the University of Manchester for a year after working for a time.

Dialysis Academy 2017 Imperial College Renal and Transplant Centre

Quality Profiles Dr. Jennifer Martin,

What are strategic clinical networks (SCN)?

Trumpcare = Tax Cuts for Rich, Insurers & Rx Drug Corporations

CVDFP Report to GPSC Dr. Jim Broere, Board Co-Chair

Patient Involvement in the HTA Decision Making Process

Some Thoughts on Improving Pavement Research Implementation

Patient Activism Charles Gore.

National Seminar Austria.

Volume 149, Issue 6, Pages (November 2015)

Professor Bryan Williams Chair of Medicine UCL

E-COMPARED Executive Committee Meeting

Internal collaboration

Dr. Simone Borsci DEC London

YOU ARE CORDIALLY INVITED TO ATTEND

Mary Adams – Patient and Public Engagement Manager

Developing a Community Peer Support model to improve access to HCV treatments for PWID. Lar Murphy,Ireland.

Monday, 23 July, 10:15-12:15 Hall 11B, RAI Amsterdam

Volume 149, Issue 6, Pages (November 2015)

Excellence Network: South East England Regional Meeting

National Collaborative Outreach Programme (NCOP)

Maths for Signals and Systems Linear Algebra in Engineering Lecture 9, Friday 1st November 2014 DR TANIA STATHAKI READER (ASSOCIATE PROFFESOR) IN SIGNAL.

Maths for Signals and Systems Linear Algebra in Engineering Lecture 18, Friday 21st November 2014 DR TANIA STATHAKI READER (ASSOCIATE PROFFESOR) IN SIGNAL.

Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.

Engaging Stakeholders in the Development and Evaluation of the Aging, Community and Health Research Unit (ACHRU) – Community Partnership Program (CPP)

IST 511 Information Management: Information and Technology

Designing nursing curriculum to meet the changing workforce needs of the Australian Health Care System Dr Anna Williams Ms Lynn Thompson Professor Sally.

LAS ACADEMY THE ROLE OF PATIENT AND PUBLIC INVOLVEMENT IN PATIENT CARE Malcolm Alexander Chair, Patients Forum for the LAS.

Presentation transcript:

HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015

LJWG Overview Chair: Dr Ashley Brown Consultant Hepatologist, St Mary’s and Hammersmith Hospitals London Honorary Senior Lecturer, Imperial College London

Why we exist – lack of joined-up care meaning that people can’t access treatment This graphic taken from our original London Consensus 2011, since updated

LJWG MISSION: To eliminate hepatitis C in drug users, and those engaged in drug services in London

LJWG Dr Kosh Agarwal Charles Gore Dr Ashley Brown Professor David Nutt Scientific Steering Committee Dr Kosh Agarwal Charles Gore Dr Ashley Brown Professor David Nutt Janet Catt Dr Magdalena Harris Dr Emily Finch Dr Mike Kelleher Professor Graham Foster Professor William Rosenberg PARTNER ORGANISATIONS: PHARMA COMPANY STAKEHOLDERS: AbbVie, MSD, Gilead Sciences and Janssen

#LJWG2015